Given that CAFs upregulated RAC3 expression (Figure 5H), our data illustrated that CAFs enhanced NSCLC cells migration via RAC3-mediated AKT/NF-κB pathway activation. This evidence concerns the gene RAC3 and non-small cell lung carcinoma.